Respiratory Syncytial Virus (RSV) is a common respiratory infection. From the 15th of May 2026 the RSV vaccine funding under the National Immunisation Program is expanding. If eligible, the RSV vacc
Influenza can vary in severity, and vaccination is one strategy that may reduce the risk of infection and its complications. The National Immunisation Program (NIP) provides funded vaccines for Medica